TuHURA Financial Statements From 2010 to 2026

HURA Stock   0.73  0.0006  0.08%   
TuHURA Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing TuHURA Biosciences' valuation are provided below:
Market Capitalization
104.6 M
Earnings Share
(0.74)
We have found one hundred twenty available fundamental trend indicators for TuHURA Biosciences, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of TuHURA Biosciences current market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 72.1 M. The current year's Enterprise Value is expected to grow to about 60.4 M
Check TuHURA Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TuHURA Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 10.2 M, Total Operating Expenses of 10.2 M or Depreciation And Amortization of 140.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0187 or PTB Ratio of 4.94. TuHURA financial statements analysis is a perfect complement when working with TuHURA Biosciences Valuation or Volatility modules.
  
Build AI portfolio with TuHURA Stock
Check out the analysis of TuHURA Biosciences Correlation against competitors.
For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.

TuHURA Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding22.5 M21.5 M3.7 M
Slightly volatile
Total Assets24.1 M23 M9.1 M
Slightly volatile
Short and Long Term Debt Total221.3 K232.9 K551.9 K
Pretty Stable
Other Current Liabilities1.3 M2.3 MM
Slightly volatile
Total Current Liabilities6.4 M6.1 M2.6 M
Slightly volatile
Accounts Payable3.8 M3.6 M1.5 M
Slightly volatile
Cash15.3 M14.6 MM
Slightly volatile
Cash And Short Term Investments15.3 M14.6 MM
Slightly volatile
Net Receivables268.9 K256.1 K101.1 K
Slightly volatile
Liabilities And Stockholders Equity24.1 M23 M9.1 M
Slightly volatile
Other Current Assets7.9 M7.5 M1.6 M
Slightly volatile
Other Stockholder Equity151.4 M144.2 M59.5 M
Slightly volatile
Total Liabilities3.9 M6.2 MM
Pretty Stable
Total Current Assets23.7 M22.6 M8.8 M
Slightly volatile
Accumulated Other Comprehensive Income18 K18.9 K2.7 M
Slightly volatile
Common Stock40 K38.1 K23.4 K
Very volatile
Non Current Assets Total433.1 K409.7 K433.8 K
Very volatile
Intangible Assets10.3 K10.9 K23 K
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Property Plant And Equipment Net314.1 K370.9 K142.1 K
Slightly volatile
Property Plant And Equipment Gross2.4 M2.8 M2.1 M
Slightly volatile
Short and Long Term Debt515.3 K579.7 K632.7 K
Slightly volatile
Capital Stock387.4 K369 K71.5 K
Slightly volatile
Short Term Debt188.4 K143.9 K491.7 K
Slightly volatile
Long Term Debt1.9 M2.1 M2.3 M
Slightly volatile
Inventory171.8 K193.2 K210.9 K
Slightly volatile

TuHURA Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses10.2 M20.3 M10.4 M
Slightly volatile
Total Operating Expenses10.2 M20.2 M10.3 M
Slightly volatile
Research Development16.1 M15.3 M6.7 M
Slightly volatile
Cost Of Revenue140.9 K134.2 K53.1 K
Slightly volatile
Selling General Administrative3.5 MM2.8 M
Slightly volatile
Reconciled Depreciation209.6 K105 K326.5 K
Slightly volatile

TuHURA Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash FlowM4.2 M5.2 M
Pretty Stable
Dividends Paid8.8 K9.2 K7.7 K
Slightly volatile
Total Cash From Financing Activities36 M34.2 M11.4 M
Slightly volatile
End Period Cash Flow7.3 M14.6 MM
Slightly volatile
Depreciation127.3 K134.2 K86.5 K
Slightly volatile
Stock Based Compensation2.4 M2.3 M889.9 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.01870.01010.0168
Very volatile
Average Payables941.3 K1.7 M1.1 M
Slightly volatile
Capex To Depreciation0.540.5723.8119
Very volatile
Inventory Turnover0.430.490.5338
Slightly volatile
Days Of Inventory On Hand537604660
Slightly volatile
Payables Turnover0.0350.03330.022
Slightly volatile
Average Inventory85.9 K96.6 K105.5 K
Slightly volatile
Cash Per Share0.740.78K
Slightly volatile
Days Payables Outstanding8.4 K8.9 K22.2 K
Slightly volatile
Income Quality0.840.780.7929
Slightly volatile
Intangibles To Total Assets0.00490.00340.0043
Slightly volatile
Net Debt To EBITDA0.460.640.5462
Pretty Stable
Current Ratio5.324.234.3968
Pretty Stable
Capex Per Share0.00340.00362.6 K
Slightly volatile
Average Receivables263.3 K250.7 K107.2 K
Slightly volatile
Interest Debt Per Share0.250.2745.781
Pretty Stable
Debt To Assets0.00870.00910.096
Very volatile
Operating Cycle537604660
Slightly volatile
Days Of Payables Outstanding8.4 K8.9 K22.2 K
Slightly volatile
Ebt Per Ebit1.241.411.1188
Slightly volatile
Quick Ratio5.324.184.3915
Pretty Stable
Net Income Per E B T0.80.90.9824
Slightly volatile
Cash Ratio4.842.733.9117
Pretty Stable
Days Of Inventory Outstanding537604660
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9833
Slightly volatile
Debt Ratio0.00870.00910.096
Very volatile

TuHURA Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap72.1 M68.7 M13.6 M
Slightly volatile

TuHURA Fundamental Market Drivers

About TuHURA Biosciences Financial Statements

TuHURA Biosciences stakeholders use historical fundamental indicators, such as TuHURA Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although TuHURA Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in TuHURA Biosciences' assets and liabilities are reflected in the revenues and expenses on TuHURA Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in TuHURA Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue134.2 K140.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:
Check out the analysis of TuHURA Biosciences Correlation against competitors.
For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74)
Return On Assets
(0.91)
Return On Equity
(3.33)
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.